The global life science Instrumentation market is projected to have a considerable CAGR during the forecast period. The market growth mainly backed by the growing various chronic diseases such as cancer, CVD coupled with increasing pharmaceutical R&D, increasing investment in the life science research, and others. The increasing popularity of cell culture in drug discovery, cancer treatment, and vaccine production has promoted the funding of cell-based research. Cell collection and separation instrument in cell harvesting procedure are used in the cell isolation process and in the collection of cells and tissues from the body. Some of the components included in the cell collection kit are cord blood collection bag, cord tissue container, vacuum-insulated panels, temperature indicator, phase-change gel packs, and a range of vials for the collection of blood. Therefore growing research in life-science further projected to be the major factor that contribute in the market growth.  

 Segmental Outlook  

The global life science Instrumentation market is segmented on the technology and End-User. Based on the technology, the market is further classified into chromatography, spectroscopy, polymerase chain reaction (pcr), clinical chemistry analyzers, immunoassays, next generation sequencing (NGS), flow cytometry, microscopy, and others( centrifuges, electrophoresis). The NGS segment is projected to have considerable growth owing to the growing technological advancement in NGS technology encourage the demand of NGS in microbiome sequencing. NGS technologies have transformed microbiome researches that result in the generation of the high volume of microbiome data. Hence, there is a requirement for advanced informatics. According to the Thermo Fisher, with the release of the Axiom Microbiome Array, an orthogonal approach to elucidation of diverse microbiota is possible. The array which incorporates sequences for more than 12,500 species facilitates simultaneous detection of viruses and protozoa and provides ease of analysis. 

 Global life science Instrumentation Market Share by End-User, 2018(%)

Global life science Instrumentation Market to be driven by Pharmaceutical & Biotechnology Companies End-User

The pharmaceutical & biotechnology companies segment held a considerable share in the market. everal pharmaceutical and biotechnology companies, such as Second Genome, Abbvie, Seres Therapeutics, OpenBiome, Vedanta Biosciences, and Enterome SA are engaged in the development drugs and diagnotics test. With the evolution of sequencing technology, these companies turned their attention to obtain information regarding the genomic profiles of microbes that surrounding the human gut. The biotech and pharma companies are using sequencing technology in order to sequence microbial samples that enable to build its capabilities to become a developer of the drug of its own. Moeorver, Cell harvesting equipment are being extensively used by the biotechnology and biopharmaceutical companies in the production of biosimilars such as monoclonal antibodies, regenerative medicine, vaccine production, and drug development, among others. Cell culture techniques are used in biotechnological companies to study the effects of new drugs, cosmetics and chemicals on survival and growth in a diverse variety of cell types, including liver and kidney-derived cell cultures. 

Regional Outlook 

Geographically, the global life science Instrumentation market is further classified into North America, Europe, Asia-Pacific and the Rest of the World. Asia-Pacific is estimated to have considerable market growth in the global market during the forecast period. The market mainly driven due to due to the increasing R&D and investments by big pharmaceutical companies in life science research. Asia-Pacific region despite economic slowdown in economies such as in India; the increasing public health care programs including the increasing private wealth is expected to boost the region’s health care spending. According to the India Brand Equity Foundation, an annual average of General Electric Co.spending has increased by 6.6% from 2015 to 2019 thus creating significant contribution in life science instrumentation market

Global life science Instrumentation Market Growth, by Region 2019-2025

North America to hold a considerable share in the global life science Instrumentation market

Geographically, North America is projected to hold a significant market share in the global life science Instrumentation market. Major economies which are anticipated to contribute to the North America genetic testing market are the US and Canada. The factors that are contributing significantly to the growth of the market include R&D investment in the bio-pharmaceutical sector and high healthcare expenditure. Accordingly, the expenditure rate of the US is more than that of Canada, as the US government invests more on R&D activities and there is more business opportunity in the US as compared to Canada. In the US, research on life sciences has increased significantly in the past years. The research areas in which microbiomes play an important role includes agriculture, human, aquatic, laboratory, built environment, terrestrial among various others. The government of the US has invested significantly in these areas so as to promote the research on microbiomes and their impact on the biological processes that further provide ample growth to the market. 

Market Players Outlook

The key players in the life science Instrumentation market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Agilent Technologies, Inc., Becton, Dickinson and Co.,  Bio-Rad Laboratories, Inc.,  Danaher Corp., Illumina, Inc., Thermo Fisher Scientific, Inc. and others. These market players adopt various strategies such as product launch, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market. 

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global life science Instrumentation market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.